DOSSIER · 13F Holders · Q3 2026
THERAVANCE BIOPHARMA CVR
1 institutions still hold THERAVANCE BIOPHARMA CVR as of Q3 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP G88CVR017·1 13F holders·last filed Sep 30, 2026
AI Holders Summary · Q3 2026
1 institutions reported THERAVANCE BIOPHARMA CVR in Q3 2026. Top-holder concentration data is loading.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.